54 414 Pill - white round
Pill with imprint 54 414 is White, Round and has been identified as Everolimus 0.25 mg. It is supplied by Hikma Pharmaceuticals PLC.
Everolimus is used in the treatment of neuroendocrine carcinoma; breast cancer; organ transplant, rejection prophylaxis; pancreatic cancer; renal angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 414
Everolimus
- Imprint
- 54 414
- Strength
- 0.25 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- MTOR inhibitors, Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Hikma Pharmaceuticals PLC
- Manufacturer
- West-Ward Columbus Inc.
- National Drug Code (NDC)
- 00054-0470
Related images for "54 414"
More about everolimus
Check interactions
Pricing & coupons
Reviews (29)
Drug images
Side effects
Dosage information
During pregnancy
Drug class: mTOR inhibitors
Patient resources
- Drug Information
- Everolimus Tablets (Afinitor)
- Everolimus Tablets (Zortress)
- Everolimus Tablets For Oral Suspension
- Breastfeeding
- En español
Other brands
Afinitor, Zortress, Afinitor Disperz
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
